• Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing Klebsiella pneumoniae infections 

      Wannigama, Dhammika Leshan; Sithu Shein, Aye Mya; Hurst, Cameron; Monk, Peter N.; Hongsing, Parichart; Phattharapornjaroen, Phatthranit; Fox Ditcham, William Graham; Ounjai, Puey; Saethang, Thammakorn; Chantaravisoot, Naphat; Wapeesittipan, Pattama; Luk-in, Sirirat; Sae-Joo, Sasipen; Nilgate, Sumanee; Rirerm, Ubolrat; Tanasatitchai, Chanikan; Kueakulpattana, Naris; Laowansiri, Matchima; Liao, Tingting; Kupwiwat, Rosalyn; Rojanathanes, Rojrit; Ngamwongsatit, Natharin; Tungsanga, Somkanya; Leelahavanichkul, Asada; Devanga Ragupathi, Naveen Kumar; Badavath, Vishnu Nayak; Hosseini Rad, S.M. Ali; Kanjanabuch, Talerngsak; Hirankarn, Nattiya; Storer, Robin James; Cui, Longzhu; Amarasiri, Mohan; Ishikawa, Hitoshi; Higgins, Paul G.; Stick, Stephen M.; Kicic, Anthony; Chatsuwan, Tanittha; Abe, Shuichi (Journal article; Peer reviewed, 2023)
      Developing an effective therapy to overcome carbapenemase-positive Klebsiella pneumoniae (CPKp) is an important therapeutic challenge that must be addressed urgently. Here, we explored a Ca-EDTA combination with aztreonam ...